Risk Issues in Dermatology: Diagnosing Melanoma is organized by Physicians Insurance/Experix and will be held during Oct 28, 2013 - May 31, 2020.
The target audience for this medical event is Dermatologists. Other interested healthcare providers are also welcome to participate. This CME Conference has been approved for a maximum of 1 CME credit.
The National Cancer Institute estimates more than 76,000 new cases and 9,480 deaths due to melanoma in 2013. Public awareness of melanoma and diagnostic scrutiny has increased, and overdiagnosis has been described in the literature. New treatments promise to improve survival rates. But delayed or missed diagnosis of melanoma is still a life-threatening risk to the patient and the most common liability risk to the dermatologist. Data from medical malpractice claims, several review articles, and a clinical practice guideline suggest strategies for reducing this risk and improving diagnosis of melanoma.
Conference Objectives are :
• Describe several types of errors implicated in the delayed diagnosis of melanoma and strategies for reducing them.
• State the essential recommended and optional data to provide to the pathologist with a biopsy specimen, according to the AAD melanoma guideline.
• State recommended procedures for handling patient refusal of recommended treatment.
Additional details will be posted as soon as they are available.